KAT-001

N/A

Report date: 2024/12/16 09:58:51
NME

Base Information

Drug NameKAT-001
Drug Alias NameKAT-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNewG Lab Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNewG Lab Pharma Inc
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A